Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep1233 | Late Breaking | ECE2024

Features of pregnancy after simultaneous pancreas-kidney transplantation in patient with type 1 diabetes mellitus (clinical case)

Yevloyeva Madina , Savitskaya Darya , Severina Anastasia , Trubitsyna Natalia , Shamkhalova Minara

Introduction: Simultaneous pancreas-kidney transplantation (SPKT) is the best way to restore normoglycemia and renal function in patients with type 1 diabetes mellitus (T1D) and end-stage renal disease (ESRD). Pregnant patients after SPKT are a high-risk group for adverse events/loss fetal and transplantation organs. These risks are significantly reduced due to pregnancy planning, regular monitoring of the woman and fetus condition with timely correction of immunosuppressive t...

ea0090ep238 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

A simultaneous pancreas-kidney transplantation for type 1 diabetes mellitus after a long-term period of hemodialysis (Clinical case)

Yevloyeva Madina , Salimkhanov Rustam , Katamadze Nino , Severina Anastasia , Shamkhalova Minara , Trubitsyna Natalia , Moysyuk Yan

Introduction: Today simultaneous pancreas-kidney transplantation (SPKT) is an effective method of treatment for patients with type 1 diabetes mellitus (T1D) and terminal stage of diabetic nephropathy (DN) on renal replacement therapy by hemodialysis. It solves several problems: reduces the severity of intoxication syndrome, contributes to the achievement of euglycemia in most cases, that allows to delay progression of micro- and macrovascular diabetic complications. Case Descr...

ea0073aep106 | Calcium and Bone | ECE2021

Mineral and bone disorders in patients after combined kidney-pancreas or kidney transplantation

Maganeva Irina , Larina Irina , Severina Anastasia , Aynetdinova Alina , Eremkina Anna , Shamkhalova Minara , Mokrysheva Natalia

BackgroundThe kidney or kidney-pancreas transplantation corrects many of the metabolic or biochemical abnormalities associated with chronic kidney disease (CKD); however, mineral bone disease (MBD) and cardiovascular pathology remain frequent in transplant recipients. This happens especially in patients who have long history of secondary hyperparathyroidism (SHPT), as well immunosuppressive therapy plays an important role in the progression of MBD.<p...